2Marr KA,Carter RA,Boeckh M,et al.Invasive aspergillosis in allogeneic stem cell transplant recipients:changes in epidemiology and risk factors.Blood,2002,100:4358-4366.
3Boogaerts M,Winston DJ,Bow EJ,et al.Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy-a randomized,controlled trial.Ann Intern Med,2001,135(6):412-422.
4Potter M,Donnelly JP.The role of itraconazole in preventing and treating systemic fungal infections in immunocompromised patients.Acta Haematol,2004,111:175-180.
2Jarvis WR . Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis, 1995,20:1526-1530.
3Kao AS, Brandt ME, Pruitt WR, et al. The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis, 1999,29:1164-1170.
4Verduyn Lunel FM, Meis JF, Voss A, et al. Nosocomial fungal infections:candidemia. Diagn Microbiol Infect Dis, 1999,34:213-220.
5Edmond MB, Wallace SE, McClish DK,et al. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis, 1999,29: 239-244.
6Beck-Sague C, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990.National Nosocomail Infections Surveillance System . J Infect Dis, 1993, 167:1247-1251.
7Haddad NE, Powderly WG. The changing face of mycoses in patients with HIV/AIDS. AIDS Read, 2001,11: 375-378.
8Rex JH, Bennett JE, Sugar AM, et al. Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group. Clin Infect Dis, 1995,21:994-996.
9Pfalller MA, Messer SA, Hollis RJ, et al. Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States. Diagn Microbiol Infect Dis, 1999,33:217-222.
10Abbas J, Bodey GP, Hanna HA, et al. Candida krusei fungemia. An escalating serious infection in immunocompromised patients. Arch Intern Med , 2000,160: 2659-2664.
8Colbum DE F J, Oladovich D. In vitro evalutation of cytochrome P 450 - mediated, drug interactions between cytarabine, idarubicine, itraconazole and caspofungin[] ]. He matology, 2004, 9(3): 217.
